These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 22697075)
1. A validated HPLC method for the monitoring of thiopurine metabolites in whole blood in paediatric patients with inflammatory bowel disease. Cangemi G; Barabino A; Barco S; Parodi A; Arrigo S; Melioli G Int J Immunopathol Pharmacol; 2012; 25(2):435-44. PubMed ID: 22697075 [TBL] [Abstract][Full Text] [Related]
2. Thiopurine metabolite monitoring in paediatric inflammatory bowel disease. Ooi CY; Bohane TD; Lee D; Naidoo D; Day AS Aliment Pharmacol Ther; 2007 Apr; 25(8):941-7. PubMed ID: 17402998 [TBL] [Abstract][Full Text] [Related]
3. Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease. Jharap B; de Boer NK; Stokkers P; Hommes DW; Oldenburg B; Dijkstra G; van der Woude CJ; de Jong DJ; Mulder CJ; van Elburg RM; van Bodegraven AA; Gut; 2014 Mar; 63(3):451-7. PubMed ID: 23424097 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic drug monitoring of thiopurine drugs in patients with inflammatory bowel disease or autoimmune hepatitis. Wusk B; Kullak-Ublick GA; Rammert C; von Eckardstein A; Fried M; Rentsch KM Eur J Gastroenterol Hepatol; 2004 Nov; 16(12):1407-13. PubMed ID: 15618853 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy. Gilissen LP; Wong DR; Engels LG; Bierau J; Bakker JA; Paulussen AD; Romberg-Camps MJ; Stronkhorst A; Bus P; Bos LP; Hooymans PM; Stockbrügger RW; Neef C; Masclee AA J Crohns Colitis; 2012 Jul; 6(6):698-707. PubMed ID: 22398098 [TBL] [Abstract][Full Text] [Related]
6. Analytical Pitfalls of Therapeutic Drug Monitoring of Thiopurines in Patients With Inflammatory Bowel Disease. Simsek M; Meijer B; Mulder CJJ; van Bodegraven AA; de Boer NKH Ther Drug Monit; 2017 Dec; 39(6):584-588. PubMed ID: 29040228 [TBL] [Abstract][Full Text] [Related]
7. Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: effect of N-acetyl transferase polymorphisms. Stocco G; Cuzzoni E; De Iudicibus S; Favretto D; Malusà N; Martelossi S; Pozzi E; Lionetti P; Ventura A; Decorti G World J Gastroenterol; 2015 Mar; 21(12):3571-8. PubMed ID: 25834322 [TBL] [Abstract][Full Text] [Related]
8. Interactions Between Thiopurine Metabolites, Adalimumab, and Antibodies Against Adalimumab in Previously Infliximab-Treated Patients with Inflammatory Bowel Disease. Holmstrøm RB; Mogensen DV; Brynskov J; Ainsworth MA; Nersting J; Schmiegelow K; Steenholdt C Dig Dis Sci; 2018 Jun; 63(6):1583-1591. PubMed ID: 29564674 [TBL] [Abstract][Full Text] [Related]
9. Usefulness of mean corpuscular volume as a surrogate marker for monitoring thiopurine treatment in inflammatory bowel disease. Dujardin RW; Meijer B; de Boer NK; D'Haens GR; Löwenberg M Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):991-6. PubMed ID: 27257870 [TBL] [Abstract][Full Text] [Related]
10. Limited stability of thiopurine metabolites in blood samples: relevant in research and clinical practise. de Graaf P; Vos RM; de Boer NH; Sinjewel A; Jharap B; Mulder CJ; van Bodegraven AA; Veldkamp AI J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(19):1437-42. PubMed ID: 20399153 [TBL] [Abstract][Full Text] [Related]
12. Does lymphopenia or macrocytosis reflect 6-thioguanine levels in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine? Heerasing NM; Ng JF; Dowling D Intern Med J; 2016 Apr; 46(4):465-9. PubMed ID: 26425841 [TBL] [Abstract][Full Text] [Related]
13. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease. Gearry RB; Barclay ML J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561 [TBL] [Abstract][Full Text] [Related]
14. Monitoring of azathioprine metabolites in pediatric patients with autoimmune hepatitis. Nguyen TM; Daubard M; Le Gall C; Larger M; Lachaux A; Boulieu R Ther Drug Monit; 2010 Aug; 32(4):433-7. PubMed ID: 20479703 [TBL] [Abstract][Full Text] [Related]
15. Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease. Haines ML; Ajlouni Y; Irving PM; Sparrow MP; Rose R; Gearry RB; Gibson PR Inflamm Bowel Dis; 2011 Jun; 17(6):1301-7. PubMed ID: 20812329 [TBL] [Abstract][Full Text] [Related]
16. Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice. Gearry RB; Barclay ML; Roberts RL; Harraway J; Zhang M; Pike LS; George PM; Florkowski CM Intern Med J; 2005 Oct; 35(10):580-5. PubMed ID: 16207256 [TBL] [Abstract][Full Text] [Related]
17. Key factors associated with 6-thioguanine and 6-methylmercaptopurine nucleotide concentrations in children treated by thiopurine for acute leukaemia and inflammatory bowel disease. de Beaumais TA; Lorrain S; Mamhoudi N; Simonin M; Martinez Vinson C; Medard Y; Petit A; Jacqz-Aigrain E Br J Clin Pharmacol; 2024 Jan; 90(1):209-219. PubMed ID: 37621013 [TBL] [Abstract][Full Text] [Related]
18. Novel assay to improve therapeutic drug monitoring of thiopurines in inflammatory bowel disease. Vikingsson S; Andersson D; Almer S; Peterson C; Hindorf U J Crohns Colitis; 2014 Dec; 8(12):1702-9. PubMed ID: 25239576 [TBL] [Abstract][Full Text] [Related]
19. Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease. Stocco G; Martelossi S; Arrigo S; Barabino A; Aloi M; Martinelli M; Miele E; Knafelz D; Romano C; Naviglio S; Favretto D; Cuzzoni E; Franca R; Decorti G; Ventura A Inflamm Bowel Dis; 2017 Apr; 23(4):628-634. PubMed ID: 28296824 [TBL] [Abstract][Full Text] [Related]